A paediatric case of myopericarditis post-COVID-19 mRNA vaccine

Yükleniyor...
Küçük Resim

Tarih

2022

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

Cambridge University Press

Erişim Hakkı

info:eu-repo/semantics/openAccess

Özet

Myopericarditis is a condition, which primarily involves the pericardium, with minimal myocardial involvement. In myopericarditis, chest pain, elevated cardiac enzymes, and electrocardiographic changes occur. Although COVID-19 mRNA vaccines significantly contribute to preventing the COVID-19 disease, rarely myocarditis and/or pericarditis may develop due to these vaccines. We present a previously healthy 14-year-old male patient who developed myopericarditis after receiving the second dose of the COVID-19 mRNA vaccine.

Açıklama

WOS:000757695200001
PMID: 35082004

Anahtar Kelimeler

mRNA vaccines, Myopericarditis, COVID-19

Kaynak

Cardiology in the Young

WoS Q Değeri

Q4

Scopus Q Değeri

Q3

Cilt

32

Sayı

10

Künye

Türe, M., Akin, A., Demir, M. ve Akay, C (2022). A paediatric case of myopericarditis post-COVID-19 mRNA vaccine. Cardiology in the Young, 32(10), 1688-1691